Literature DB >> 18452802

Lyme arthritis: pathogenesis, clinical presentation, and management.

Yoram A Puius1, Robert A Kalish.   

Abstract

Arthritis is one of the most prominent features of Lyme disease, the tick-borne illness caused by Borrelia burgdorferi. Although the pathogenesis of Lyme arthritis is complex and still under study, the clinical presentation and natural history have been established by long-term observation of untreated and treated patients. This review addresses the clinical presentation of Lyme arthritis as a mono- or oligoarticular relapsing/remitting arthritis primarily affecting the large joints and describes presentations in which arthralgias rather than arthritis are seen. Strategies for diagnosis and treatment are discussed, and methods are reviewed for addressing treatment-refractory Lyme arthritis and arthralgias that may occur after treatment of Lyme disease (sometimes as a component of what is known as the post-Lyme disease syndrome).

Entities:  

Mesh:

Year:  2008        PMID: 18452802     DOI: 10.1016/j.idc.2007.12.014

Source DB:  PubMed          Journal:  Infect Dis Clin North Am        ISSN: 0891-5520            Impact factor:   5.982


  15 in total

1.  Identifying Vancomycin as an Effective Antibiotic for Killing Borrelia burgdorferi.

Authors:  Xiaoqian Wu; Bijaya Sharma; Samantha Niles; Kathleen O'Connor; Rebecca Schilling; Nicole Matluck; Anthony D'Onofrio; Linden T Hu; Kim Lewis
Journal:  Antimicrob Agents Chemother       Date:  2018-10-24       Impact factor: 5.191

Review 2.  Lyme disease and the orthopaedic implications of lyme arthritis.

Authors:  Brian G Smith; Aristides I Cruz; Matthew D Milewski; Eugene D Shapiro
Journal:  J Am Acad Orthop Surg       Date:  2011-02       Impact factor: 3.020

3.  Identification of residues within ligand-binding domain 1 (LBD1) of the Borrelia burgdorferi OspC protein required for function in the mammalian environment.

Authors:  Christopher G Earnhart; Delacy V Leblanc; Katie E Alix; Daniel C Desrosiers; Justin D Radolf; Richard T Marconi
Journal:  Mol Microbiol       Date:  2010-02-28       Impact factor: 3.501

4.  Borrelia burgdorferi, the Causative Agent of Lyme Disease, Forms Drug-Tolerant Persister Cells.

Authors:  Bijaya Sharma; Autumn V Brown; Nicole E Matluck; Linden T Hu; Kim Lewis
Journal:  Antimicrob Agents Chemother       Date:  2015-05-26       Impact factor: 5.191

5.  Genetic Background Amplifies the Effect of Immunodeficiency in Antibiotic Efficacy Against Borrelia burgdorferi.

Authors:  Bijaya Sharma; Julie E McCarthy; Cecily A Freliech; Morgen M Clark; Linden T Hu
Journal:  J Infect Dis       Date:  2021-07-15       Impact factor: 5.226

6.  Nod2 suppresses Borrelia burgdorferi mediated murine Lyme arthritis and carditis through the induction of tolerance.

Authors:  Tanja Petnicki-Ocwieja; Alicia S DeFrancesco; Erin Chung; Courtney T Darcy; Roderick T Bronson; Koichi S Kobayashi; Linden T Hu
Journal:  PLoS One       Date:  2011-02-28       Impact factor: 3.240

7.  Lyme disease: case report of persistent Lyme disease from Pulaski County, Virginia.

Authors:  James R Palmieri; Scott King; Matthew Case; Arben Santo
Journal:  Int Med Case Rep J       Date:  2013-12-05

8.  CspA from Borrelia burgdorferi inhibits the terminal complement pathway.

Authors:  Teresia Hallström; Corinna Siegel; Matthias Mörgelin; Peter Kraiczy; Christine Skerka; Peter F Zipfel
Journal:  mBio       Date:  2013-08-13       Impact factor: 7.867

9.  Strain-specific variation of the decorin-binding adhesin DbpA influences the tissue tropism of the lyme disease spirochete.

Authors:  Yi-Pin Lin; Vivian Benoit; Xiuli Yang; Raúl Martínez-Herranz; Utpal Pal; John M Leong
Journal:  PLoS Pathog       Date:  2014-07-31       Impact factor: 6.823

10.  Tocilizumab Efficacy in a Patient with Positive Anti-CCP Chronic Lyme Arthritis.

Authors:  Julianna Hirsch; Itzhak Rosner; Doron Rimar; Lisa Kaly; Michael Rozenbaum; Nina Boulman; Gleb Slobodin
Journal:  N Am J Med Sci       Date:  2016-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.